News
Pharmalittle: We’re reading about an FDA rejection, the Big Beautiful Bill’s cost, and much more
The FDA's top regulator of cancer drugs interceded in a review of a Replimune skin cancer therapy, contributing to its ...
The FDA will soon require prescription opioid manufacturers to include stronger language on the medications’ label warning ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback